TXG
10x Genomics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TXG fundamentals
10x Genomics (TXG) released its earnings on Nov 6, 2025: revenue was 149.00M (YoY -1.78%), beat estimates; EPS was -0.22 (YoY +26.67%), missed estimates.
Revenue / YoY
149.00M
-1.78%
EPS / YoY
-0.22
+26.67%
Report date
Nov 6, 2025
TXG Earnings Call Summary for Q3,2025
- Revenue Growth: Q3 revenue of $149M exceeded guidance, with spatial consumables up 19% YoY and Flex-driven single-cell growth.
- Product Innovation: Xenium protein launch enables multi-omics analysis; Flex v2 reduces cost per sample for large-scale experiments.
- Market Momentum: Europe and China show resilience; Xenium adoption outpaces Visium.
- Financial Strength: $482M cash provides flexibility; Q4 guidance of $154-158M reflects steady growth.
- Strategic Focus: Virtual cell modeling and clinical collaborations drive long-term potential.
EPS
Revenue
Revenue & Expenses
TXG has released its 2025 Q3 earnings report, with revenue of 149.00M, reflecting a YoY change of -1.75%, and net profit of -27.47M, showing a YoY change of 23.16%. The Sankey diagram below clearly presents TXG's revenue sources and cost distribution.
Key Indicators
10x Genomics (TXG) key financial stats and ratios, covering profitability, financial health, and leverage.
10x Genomics (TXG)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
10x Genomics (TXG)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
10x Genomics (TXG)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does 10x Genomics (TXG) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track 10x Genomics (TXG) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did 10x Genomics's management provide for the next earnings period?What is the market's earnings forecast for 10x Genomics next quarter?What factors drove the changes in 10x Genomics's revenue and profit?Did 10x Genomics beat or miss consensus estimates last quarter?What is 10x Genomics's gross profit margin?What is the revenue and EPS growth rate for 10x Genomics year over year?What were the key takeaways from 10x Genomics's earnings call?What were the key takeaways from 10x Genomics’s earnings call?
